NCT02764554已完成不适用
Post-Marketing Surveillance of Lenvima in Korean Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 132
- 试验地点
- 32
- 主要终点
- Number of Participants with Adverse Events, Serious Adverse Events, and Adverse Drug Reactions
研究概览
简要总结
The purpose of this post-marketing surveillance (PMS) is to observe the safety profile of Lenvima (lenvatinib) in normal clinical practice setting.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Investigators will refer to approved indications and contraindications regarding exclusion criteria
结局指标
主要结局
Number of Participants with Adverse Events, Serious Adverse Events, and Adverse Drug Reactions
时间窗: Up to 1 year
次要结局
未报告次要终点
研究者
研究点 (32)
Loading locations...
相似试验
已完成
不适用
A Study of Fycompa (Perampanel) in Korean ParticipantsEpilepsyNCT02722590Eisai Korea Inc.3,692
已完成
4 期
Post Marketing Surveillance for ADACEL™ in South KoreaPertussisTetanusDiphtheriaNCT01137435Sanofi Pasteur, a Sanofi Company659
已完成
不适用
Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)Hepatitis ANCT01838070Sanofi Pasteur, a Sanofi Company614
撤回
不适用
A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and NeckNeoplasms, Squamous CellNCT01075841Merck KGaA, Darmstadt, Germany
招募中
不适用
Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea PatientsHyperphosphatemiaNCT06186934Kyowa Kirin Korea Co., Ltd.600